Satellos Bioscience 

€6.05
0
+€0.1+1.68% Wednesday 19:47

Statistics

Day High
6.05
Day Low
6.05
52W High
9.54
52W Low
3.86
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2JunExpected
Q4 2025
Next
-0.44
-0.4
-0.36
-0.33
Expected EPS
-0.41242508086824
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0IT.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Francis Gleeson B.B.A. M.B.A
Employees
18
Country
Canada
ISIN
CA80401L8033

Listings

0 Comments

Share your thoughts

FAQ

What is Satellos Bioscience stock price today?
The current price of 0IT.STU is €6.05 EUR — it has increased by +1.68% in the past 24 hours. Watch Satellos Bioscience stock price performance more closely on the chart.
What is Satellos Bioscience stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Satellos Bioscience stocks are traded under the ticker 0IT.STU.
Is Satellos Bioscience stock price growing?
0IT.STU stock has fallen by -33.66% compared to the previous week, the month change is a -33.66% fall, over the last year Satellos Bioscience has showed a +29.94% increase.
When is the next Satellos Bioscience earnings date?
Satellos Bioscience is going to release the next earnings report on June 02, 2026.
What were Satellos Bioscience earnings last quarter?
0IT.STU earnings for the last quarter are -0.44 EUR per share, whereas the estimation was -0.33 EUR resulting in a -34.21% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Satellos Bioscience have?
As of April 16, 2026, the company has 18 employees.
In which sector is Satellos Bioscience located?
Satellos Bioscience operates in the Other sector.
When did Satellos Bioscience complete a stock split?
Satellos Bioscience has not had any recent stock splits.
Where is Satellos Bioscience headquartered?
Satellos Bioscience is headquartered in Toronto, Canada.